What Is Myelodysplastic Syndrome?

The myelodysplastic syndromes (MDS) or myelodysplasia refers to a group of primary, neoplastic stem cell disorders. This group of stem cell disorders are described to have one of the following:

– Active but inefficient production of white cells, red blood cells, and/or platelets

– Prominent maturation abnormalities (dyspoiesis or dysplasia) in the bone marrow

– Morphological abnormalities of peripheral blood and bone marrow

– One or more peripheral blood cytopenias

What are the available treatments for Myelodysplastic Syndrome?

There are a number of options for treatment for myelodysplastic syndromes. This includes:

1. Supportive care measures

Therapy of MDS has been the most common form of treatment for Australians with Myelodysplastic Syndrome.

2. Stem cell transplantation

Stem cell transplantation therapy is only suitable for patients who are of suitable age. Many patients are unable to receive this option for treatment because of their advanced age.

3. Clinical trials

Clinical trials are often classed as innovative approaches that patients can trial if they fit the criteria. Clinical trials are available depending on the status of your illness. Speak to your health professional for more advice on the availability of clinical trials.
to the treatment of MDS